Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease.

Saved in:
Bibliographic Details
Title: Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease.
Authors: Sakr SM; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Desai S; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Medina-Inojosa J; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Liu C; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA., Razavi AC; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Yadalam AK; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Ko YA; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA., Ahmed T; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Harris KA; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Huang J; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Yeboah R; Department of Development Practice, Laney Graduate School, Emory University, Atlanta, GA., Haroun N; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Hartsfield JD; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Owais M; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Lodhi R; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Eldaidamouni AA; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Al Kasem M; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Ali MK; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA.; Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, GA., Narayan KMV; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA.; Emory Global Diabetes Research Center, Woodruff Health Sciences Center, Emory University, Atlanta, GA., Pasquel FJ; Division of Endocrinology, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Tandon N; Department of Endocrinology & Metabolism, All India Institute of Medical Sciences, New Delhi, India., Mohan V; Department of Diabetology, Dr. Mohan's Diabetes Specialities Centre, Madras Diabetes Research Foundation, Chennai, India., Quyyumi AA; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Source: Diabetes care [Diabetes Care] 2026 Mar 01; Vol. 49 (3), pp. 450-459.
Publication Type: Journal Article
Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1935-5548
DOI:10.2337/dc25-0940